AccuStem Q2 FY26 net loss narrows 37% to $252,573

Reuters2026/08/14 20:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AccuStem posted a net loss of USD 252,573 for the quarter ended June 30, 2026, narrowing 37% year over year.
Other income turned positive to USD 98,400, due to one-off supplier invoice credits deemed no longer due and payable.
Research and development expense fell 27% to USD 43,712, primarily on timing of technology-transfer spending.
General and administrative costs declined 10% to USD 307,261, mainly due to no payroll-related bonus costs in 2026.
Cash and cash equivalents totaled USD 12,928 at June 30, 2026; existing cash is expected to fund operations until August 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accustem Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038323), on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AccuStem Q2 FY26 net loss narrows 37% to $252,573

You may also like

Crypto prices